4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-20-005529
President and CEO acquired 15,450 shares (option exercise)
- President and CEO gave up 5,343 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Culley Brian M President and CEO | 2020-03-31 | Option exercise | +15,450 | $0.83 | $12,794 | 160,624 | D: show line 1 in the form |
| Culley Brian M President and CEO | 2020-03-31 | Shares withheld for taxes | −5,343 | $0.83 | $4,425 | 155,281 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Culley Brian M President and CEO | 2020-03-31 | Option exercise · Restricted Stock Units | −15,450 | 139,050 | D: show line 3 in the form |
Loading xslF345X03/ownership.xml…